Tin tức & Cập nhật

In the treatment of patients with juvenile idiopathic arthritis (JIA), tofacitinib appears to maintain its efficacy for up to 48 months, with the safety findings consistent with the known safety profile of the drug, according to the results of a long-term extension (LTE) study.

Lebrikizumab and dupilumab appear to be equally efficacious when used in the short-term treatment of atopic dermatitis in adults, according to the results of a network meta-analysis.

The JAK inhibitor upadacitinib brought sustained remission in the first 52 weeks of the phase III SELECT-GCA study of patients with new-onset or relapsing giant cell arteritis (GCA).

The use of abatacept as a first-line biologic treatment appears to result in greater remission in rheumatoid arthritis (RA), especially if the drug is used continuously, as shown in a real-world study from Taiwan.

Hysterosalpingography (HSG) with an oil-based contrast medium yields a significantly higher rate of ongoing pregnancy and live birth than HSG with a water-soluble contrast medium, according to a study presented at ESHRE 2024.